NextCell Pharma AB (STO:NXTCL)
Sweden · Delayed Price · Currency is SEK 0.2865
+0.0330 (13.02%)
Nov 3, 2026, 5:25 PM CET
NextCell Pharma AB Market Cap
NextCell Pharma AB has a market cap or net worth of 36.21 million as of November 3, 2026. It is the 46,014th most valuable company in the world and the 706th biggest in Sweden. Its market cap has decreased by 64.04% in one year.
Market Cap
36.21M
Enterprise Value
15.12M
Revenue
10.78M
Global Rank
Country Rank
#706 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since July 13, 2017, NextCell Pharma AB's market cap has increased from 33.03M to 36.21M, an increase of 9.65%. That is a compound annual growth rate of 0.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 36.21M | -55.53% |
| Dec 30, 2025 | 81.43M | -60.77% |
| Dec 30, 2024 | 207.58M | 129.58% |
| Dec 29, 2023 | 90.42M | -62.64% |
| Dec 30, 2022 | 242.03M | -9.28% |
| Dec 30, 2021 | 266.79M | -35.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OncoZenge AB | 85.84M |
| Ascelia Pharma AB | 77.45M |
| Pila Pharma AB | 71.26M |
| AcouSort AB | 68.15M |
| Annexin Pharmaceuticals AB | 57.89M |
| Nanologica AB | 54.25M |
| Fluicell AB | 38.33M |
| Spago Nanomedical AB | 32.09M |